| Product Code: ETC7908145 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Communicable Diseases Treatment Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Communicable Diseases Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Communicable Diseases Treatment Market - Industry Life Cycle |
3.4 Latvia Communicable Diseases Treatment Market - Porter's Five Forces |
3.5 Latvia Communicable Diseases Treatment Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Latvia Communicable Diseases Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Latvia Communicable Diseases Treatment Market Revenues & Volume Share, By Infectious Agent, 2021 & 2031F |
3.8 Latvia Communicable Diseases Treatment Market Revenues & Volume Share, By Mode of Transmission, 2021 & 2031F |
3.9 Latvia Communicable Diseases Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.10 Latvia Communicable Diseases Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Latvia Communicable Diseases Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of communicable diseases in Latvia |
4.2.2 Government initiatives to improve healthcare infrastructure and access to treatment |
4.2.3 Technological advancements in healthcare for better diagnosis and treatment |
4.3 Market Restraints |
4.3.1 Limited healthcare budget allocation for communicable diseases treatment |
4.3.2 Lack of awareness about prevention and early treatment of communicable diseases |
4.3.3 Resistance to antibiotics and emergence of drug-resistant strains |
5 Latvia Communicable Diseases Treatment Market Trends |
6 Latvia Communicable Diseases Treatment Market, By Types |
6.1 Latvia Communicable Diseases Treatment Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Gastroenteritis, 2021- 2031F |
6.1.4 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Gonorrhoea, 2021- 2031F |
6.1.5 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Whooping Cough, 2021- 2031F |
6.1.6 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Common Cold, 2021- 2031F |
6.1.7 Latvia Communicable Diseases Treatment Market Revenues & Volume, By HIV/AIDS, 2021- 2031F |
6.1.8 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Pink Eye, 2021- 2031F |
6.1.9 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Latvia Communicable Diseases Treatment Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Vaccine, 2021- 2031F |
6.2.3 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Therapeutics, 2021- 2031F |
6.2.4 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Antibiotics, 2021- 2031F |
6.2.5 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Antivirals, 2021- 2031F |
6.2.6 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Antifungal, 2021- 2031F |
6.2.7 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Antiparasitics, 2021- 2031F |
6.2.8 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2.9 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Latvia Communicable Diseases Treatment Market, By Infectious Agent |
6.3.1 Overview and Analysis |
6.3.2 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Bacteria, 2021- 2031F |
6.3.3 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Viruses, 2021- 2031F |
6.3.4 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Fungi/Parasites, 2021- 2031F |
6.4 Latvia Communicable Diseases Treatment Market, By Mode of Transmission |
6.4.1 Overview and Analysis |
6.4.2 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Direct Contact, 2021- 2031F |
6.4.3 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Person-to-person Contact, 2021- 2031F |
6.4.4 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Droplet Spread, 2021- 2031F |
6.4.5 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4.6 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Indirect Contact, 2021- 2031F |
6.4.7 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Airborne Transmission, 2021- 2031F |
6.4.8 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Food and Drinking Water, 2021- 2031F |
6.4.9 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Food and Drinking Water, 2021- 2031F |
6.5 Latvia Communicable Diseases Treatment Market, By Type |
6.5.1 Overview and Analysis |
6.5.2 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Sexually Transmitted Diseases, 2021- 2031F |
6.5.3 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Helminthic Diseases, 2021- 2031F |
6.5.4 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Contact Communicable Diseases, 2021- 2031F |
6.5.5 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Oral Contamination Diseases, 2021- 2031F |
6.5.6 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Air Borne Diseases, 2021- 2031F |
6.6 Latvia Communicable Diseases Treatment Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.4 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.5 Latvia Communicable Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Latvia Communicable Diseases Treatment Market Import-Export Trade Statistics |
7.1 Latvia Communicable Diseases Treatment Market Export to Major Countries |
7.2 Latvia Communicable Diseases Treatment Market Imports from Major Countries |
8 Latvia Communicable Diseases Treatment Market Key Performance Indicators |
8.1 Number of patients receiving timely treatment for communicable diseases |
8.2 Rate of successful treatment outcomes |
8.3 Adoption rate of new technologies and treatment methods in healthcare practice |
9 Latvia Communicable Diseases Treatment Market - Opportunity Assessment |
9.1 Latvia Communicable Diseases Treatment Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Latvia Communicable Diseases Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Latvia Communicable Diseases Treatment Market Opportunity Assessment, By Infectious Agent, 2021 & 2031F |
9.4 Latvia Communicable Diseases Treatment Market Opportunity Assessment, By Mode of Transmission, 2021 & 2031F |
9.5 Latvia Communicable Diseases Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.6 Latvia Communicable Diseases Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Latvia Communicable Diseases Treatment Market - Competitive Landscape |
10.1 Latvia Communicable Diseases Treatment Market Revenue Share, By Companies, 2024 |
10.2 Latvia Communicable Diseases Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here